Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Moberg Pharma AB (publ) (MB8.F) Follow Add holdings 0.6740 -0.0105 (-1.53%) At close: April 25 at 8:06:40 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for MB8.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: MB8.F View More All News Press Releases SEC Filings Terclara (MOB-015) is now being launched in Norway Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU Cipher Pharmaceuticals Down 16% as Partner Moberg Pharma AB Provides Lower Than Expected Study Results Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98% Moberg Pharma has secured exercise of warrants and entered into a top guarantee free of charge